|
Risk Factors
Citations 491-500 of 1535 total displayed.
|
Past content
(since Jan 1999):
|
- Articles
Relationship Between Homocysteine and Mortality in Chronic Kidney Disease
- Vandana Menon, Mark J. Sarnak, Tom Greene, Xuelei Wang, Arema A. Pereira, Gerald J. Beck, John W. Kusek, Jacob Selhub, Allan J. Collins, Andrew S. Levey, and Michael G. Shlipak
Circulation published March 20, 2006, doi:10.1161/CIRCULATIONAHA.105.570127
[Abstract]
- Contemporary Reviews in Cardiovascular Medicine
Assessing and Reducing the Cardiac Risk of Noncardiac Surgery
- Andrew Auerbach and Lee Goldman
Circulation 2006;113:1361-1376, doi:10.1161/CIRCULATIONAHA.105.573113
[Full text]
- Articles
Nonsteroidal Antiinflammatory Drugs, Acetaminophen, and the Risk of Cardiovascular Events
- Andrew T. Chan, JoAnn E. Manson, Christine M. Albert, Claudia U. Chae, Kathryn M. Rexrode, Gary C. Curhan, Eric B. Rimm, Walter C. Willett, and Charles S. Fuchs
Circulation published March 13, 2006, doi:10.1161/CIRCULATIONAHA.105.595793
[Abstract]
- Articles
Contribution of Clinical Correlates and 13 C-Reactive Protein Gene Polymorphisms to Interindividual Variability in Serum C-Reactive Protein Level
- Sekar Kathiresan, Martin G. Larson, Ramachandran S. Vasan, Chao-Yu Guo, Philimon Gona, John F. Keaney, Jr, Peter W.F. Wilson, Christopher Newton-Cheh, Stacy L. Musone, Amy L. Camargo, Jared A. Drake, Daniel Levy, Christopher J. O’Donnell, Joel N. Hirschhorn, and Emelia J. Benjamin
Circulation published March 13, 2006, doi:10.1161/CIRCULATIONAHA.105.591271
[Abstract]
- Articles
A Tale of Two Trials. A Comparison of the Post-Acute Coronary Syndrome Lipid-Lowering Trials A to Z and PROVE IT-TIMI 22
- Stephen D. Wiviott, James A. de Lemos, Christopher P. Cannon, Michael Blazing, Sabina A. Murphy, Carolyn H. McCabe, Robert Califf, and Eugene Braunwald
Circulation published March 13, 2006, doi:10.1161/CIRCULATIONAHA.105.586347
[Abstract]
- Articles
Low-Density Lipoprotein and High-Density Lipoprotein Particle Subclasses Predict Coronary Events and Are Favorably Changed by Gemfibrozil Therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial
- James D. Otvos, Dorothea Collins, David S. Freedman, Irina Shalaurova, Ernst J. Schaefer, Judith R. McNamara, Hanna E. Bloomfield, and Sander J. Robins
Circulation published March 13, 2006, doi:10.1161/CIRCULATIONAHA.105.565135
[Abstract]
- Correspondence
Letter Regarding Article by Ruttmann et al, " -Glutamyltransferase as a Risk Factor for Cardiovascular Disease Mortality: An Epidemiological Investigation in a Cohort of 163 944 Austrian Adults"
- Philippe Giral, Vlad Ratziu, John C. Chapman, Elfriede Ruttmann, Hanno Ulmer, Larry J. Brant, Hans Concin, Günter Diem, and Kilian Rapp
Circulation 2006;113:e299-300e, doi:10.1161/CIRCULATIONAHA.105.594176
[Full text]
- Editorials
Level of Kidney Function Determines Cardiovascular Fate After Coronary Bypass Graft Surgery
- Panteleimon A. Sarafidis and George L. Bakris
Circulation 2006;113:1046-1047, doi:10.1161/CIRCULATIONAHA.105.609289
[Full text]
- Cardiovascular Surgery
Impact of Renal Dysfunction on Outcomes of Coronary Artery Bypass Surgery: Results From the Society of Thoracic Surgeons National Adult Cardiac Database
- William A. Cooper, Sean M. O’Brien, Vinod H. Thourani, Robert A. Guyton, Charles R. Bridges, Lynda A. Szczech, Rebecca Petersen, and Eric D. Peterson
Circulation 2006;113:1063-1070; published online before print as doi:10.1161/CIRCULATIONAHA.105.580084
[Abstract]
[Full text]
- Editorials
Bacteria and Coronary Atheroma: More Fingerprints but No Smoking Gun
- Joel T. Katz and Richard P. Shannon
Circulation 2006;113:920-922, doi:10.1161/CIRCULATIONAHA.105.607358
[Full text]
|
|
